Material Agreements

CROWN CASTLE INC. entered into Sales Agreements with certain sales agents valued at up to $750,000,000 (effective 2024-03-20).

“On March 20, 2024, Crown Castle Inc. (“Company”) entered into sales agreements (“Sales Agreements”) with each of BofA Securities, Inc., Barclays Capital Inc., BNP Paribas Securities Corp., BTIG, LLC, Citigroup Global Markets Inc., Credit Agricole Securities (USA) Inc., Jefferies LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Scotia Capital (USA) Inc., SG Americas Securities, LLC, TD Securities (USA) LLC and Truist Securities, Inc. (each, a “Sales Agent” and collectively, “Sales Agents”), pursuant to which the Company may issue and sell from time to time shares (“Shares”) of its common stock, par value $0.01 per share (“Common Stock”), having an aggregate gross sales price of up to $750,000,000.”

AFFILIATED MANAGERS GROUP, INC. entered into Underwriting Agreement with BofA Securities, Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, and Wells Fargo Securities, LLC (effective 2024-03-14).

“On March 14, 2024, the Company also entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, and Wells Fargo Securities, LLC, as representatives of the underwriters named therein.”

AFFILIATED MANAGERS GROUP, INC. entered into Fourth Supplemental Indenture with U.S. Bank National Association and U.S. Bank Trust Company, National Association valued at $450,000,000 aggregate principal amount (effective 2024-03-20).

“On March 20, 2024, Affiliated Managers Group, Inc. (the “Company”) completed the issuance and sale of $450,000,000 aggregate principal amount of the Company’s 6.750% Junior Subordinated Notes due 2064 (the “Initial Securities”), including $50,000,000 aggregate principal amount of the Company’s 6.750% Junior Subordinated Notes due 2064, pursuant to the underwriters’ option to purchase additional notes to cover over-allotments (together with the Initial Securities, the “Securities”).”

GLOBAL TECHNOLOGIES LTD entered into Share Exchange Agreement with GOe3, LLC (effective 2024-03-15).

“.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT Share Exchange Agreement As previously disclosed on the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 6, 2024, the”

Hyperscale Data, Inc. entered into Agreement with Ault & Company, Inc. valued at $50 million (effective 2023-11-06).

“On each of March 18, 2024 and March 19, 2024, Ault Alliance, Inc., a Delaware corporation (the “ Company ”), pursuant to the Securities Purchase Agreement (the “ Agreement ”) entered into with Ault & Company, Inc., a Delaware corporation (the “ Purchaser ”) on November 6, 2023 (the “ Execution Date ”), sold 500 shares of Series C convertible preferred stock (the “ Series C Convertible Preferred Stock ”), and warrants (the “ Series C Warrants ”) to purchase 147,820 shares (the “ Warrant Shares ”) of the Company’s common stock to the Purchaser, for a purchase price of 500,000.”

DELCATH SYSTEMS, INC. entered into Securities Purchase Agreement with certain accredited investors valued at sale of 876,627 shares at $3.72/share and 1,008,102 pre-funded warrants at $3.71/warrant, gross proc (effective 2024-03-14).

“On March 14, 2024, Delcath Systems, Inc. (the “Company”) and certain accredited investors (each an “Investor” and collectively, the “Investors”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) pursuant to which the Company agreed to sell and issue to the Investors in a private placement (the “Private Placement”) (i) an aggregate of 876,627 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a purchase price of $3.72 per share, and (ii) to certain investors, in lieu of shares of Common Stock, 1,008,102 pre-funded warrants (the “Pre-Funded Warrants”) at a price per Pre-Funded Warrant of $3.71 (the “Warrant Shares” and together with the Shares, the “Securities”).”

HONEYWELL INTERNATIONAL INC terminated $1.5 billion 364-day credit agreement dated as of March 20, 2023 with Bank of America, N.A. valued at termination of commitments under the prior credit agreement (effective 2024-03-18).

“On March 18, 2024, Honeywell terminated the commitments under its $1.5 billion 364-day credit agreement dated as of March 20, 2023, among Honeywell, the lenders party thereto and Bank of America, N.A., as administrative agent.”

HONEYWELL INTERNATIONAL INC entered into Amended and Restated Five Year Credit Agreement with Bank of America, N.A., JPMorgan Chase Bank, N.A., Wells Fargo Bank, National Association valued at revolving credit commitments in aggregate principal amount of $4.0 billion, can be increased to $4.5 (effective 2024-03-18).

“On March 18, 2024, Honeywell entered into an Amended and Restated Five Year Credit Agreement (the “ 5-Year Credit Agreement ”) with the banks, financial institutions, and other institutional lenders party thereto, Bank of America, N.A., as administrative agent, Bank of America, N.A., as swing line agent, and JPMorgan Chase Bank, N.A. and Wells Fargo Bank, National Association, as syndication agents, and the documentation agents named therein.”

HONEYWELL INTERNATIONAL INC entered into 364-Day Credit Agreement with Bank of America, N.A., JPMorgan Chase Bank, N.A., Wells Fargo Bank, National Association valued at revolving credit commitments in aggregate principal amount of $1.5 billion for general corporate pur (effective 2024-03-18).

“On March 18, 2024, Honeywell International Inc. (“ Honeywell ”) entered into a 364-Day Credit Agreement (the “ 364-Day Credit Agreement ”) with the banks, financial institutions and other institutional lenders party thereto, Bank of America, N.A., as administrative agent, and JPMorgan Chase Bank, N.A. and Wells Fargo Bank, National Association, as syndication agents, and the documentation agents named therein.”

PENNSYLVANIA REAL ESTATE INVESTMENT TRUST amended Second Amendment with creditors holding over 50.1% of the loans outstanding under the Debtors' first lien credit agreement and over 50.1% of the loans outstanding under the Debtors' second lien credit agreement (effective 2024-03-13).

“On March 13, 2024, Pennsylvania Real Estate Investment Trust and certain of its direct and indirect subsidiaries (collectively, the “ Debtors ”) entered into the Second Amendment to Restructuring Support Agreement (the “ Second Amendment ”), with creditors holding over 50.1% of the loans outstanding under the Debtors’ first lien credit agreement and over 50.1% of the loans outstanding under the Debtors’ second lien credit agreement (collectively, the “ Amendment Consenting Lenders ”).”

Cheniere Energy, Inc. entered into Registration Rights Agreement with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, BBVA Securities Inc., Mizuho Securities USA LLC, Scotia Capital (USA) Inc. and Truist Securities, Inc. (effective 2024-03-19).

“Cheniere and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, BBVA Securities Inc., Mizuho Securities USA LLC, Scotia Capital (USA) Inc. and Truist Securities, Inc., as representatives of the initial purchasers, entered into a Registration Rights Agreement dated as of the Issue Date (the “Registration Rights Agreement”).”

Cheniere Energy, Inc. entered into First Supplemental Indenture with The Bank of New York Mellon valued at $1.5 billion (effective 2024-03-19).

“The Notes were issued on the Issue Date pursuant to an indenture, dated as of the Issue Date (the “Base Indenture”), by and between Cheniere and The Bank of New York Mellon, as trustee (the “Trustee”), as supplemented by the first supplemental indenture, dated as of the Issue Date, between Cheniere and the Trustee, relating to the Notes (the “First Supplemental Indenture”).”

Cheniere Energy, Inc. entered into Base Indenture with The Bank of New York Mellon valued at $1.5 billion (effective 2024-03-19).

“On March 19, 2024 (the “Issue Date”), Cheniere Energy, Inc. (“Cheniere”) closed the sale of its previously announced offering of $1.5 billion aggregate principal amount of 5.650% senior notes due 2034”

Bright Green Corp entered into Settlement Agreement with the Sellers, Alterola, and United (effective 2024-03-13).

“On March 13, 2024, the Company entered into a settlement agreement and release (the “Settlement Agreement”) with the Sellers, Alterola, and United, pursuant to which, among other things, the Company agreed to transfer 118,535,168 Alterola Shares to United and transfer an aggregate of 83,226,820 Alterola Shares, in the proportion of 27,742,273 shares to each of Equipped, Phyto and TPR.”

Bright Green Corp entered into Credit Agreement with JVR Holdings valued at $60 million (effective 2024-03-14).

“On March 14, 2024, Bright Green Corporation, a Delaware corporation (“Company”) entered into a credit agreement (the “Credit Agreement”) with JVR Holdings (the “Lender”), pursuant to which the Lender agreed to provide the Company with a line of credit facility (the “Line of Credit”) up to a maximum amount of $60 million”

Drilling Tools International Corp entered into Second Amended and Restated Revolving Credit, Term Loan and Security and Guaranty Agreement with PNC Bank, National Association valued at revolving line of credit up to $80,000,000 and term loan of $25,000,000 (effective 2024-03-15).

“On March 15, 2024, Drilling Tools International Corporation (the “ Company ”) refinanced its revolving credit facility (the “ Refinancing ”) by entering into a Second Amended and Restated Revolving Credit, Term Loan and Security and Guaranty Agreement (the “ Credit Facility ”) with certain of the Company’s subsidiaries and PNC Bank, National Association as lender and as agent (“ PNC ”).”

Cadre Holdings, Inc. entered into Underwriting Agreement with BofA Securities, Inc., as representative of the several underwriters (effective 2024-03-14).

“On March 14, 2024, Cadre Holdings, Inc., a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”), among the Company, Kanders SAF, LLC, a Delaware limited liability company and a stockholder of the Company (the “Selling Stockholder”), and BofA Securities, Inc. (“BofA”), as representative of the several underwriters named therein (collectively, the “Underwriters”), relating to the primary public offering (the “Primary Offering”) of 2,200,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) by the Company and the secondary offering (the “Secondary Offering” and together with the Primary Offering, collectively hereinafter referred to as the “Offering”) of 1,438,127 shares of Common Stock by the Selling Stockholder, at a price to the public of $35.00 per share.”

MOBIX LABS, INC entered into Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC valued at up to $100,000,000 (effective 2024-03-18).

“On March 18, 2024, Mobix Labs, Inc. (the “ Company ”) entered into a Common Stock Purchase Agreement (the “ Purchase Agreement ”) and a related Registration Rights Agreement (the “ Registration Rights Agreement ”), each dated as of March 18, 2024, with B. Riley Principal Capital II, LLC (“ B. Riley Principal Capital II ”).”

AleAnna, Inc. amended Second Trust Amendment with Continental Share Transfer & Trust Company (effective 2024-03-15).

“On March 15, 2024, the shareholders of Swiftmerge Acquisition Corp. (the “ Company ”) at the reconvened extraordinary general meeting of the Company which had been adjourned from March 13, 2024 (the “ Meeting ”) approved an amendment (the “ Second Trust Amendment ”) of that certain investment management trust agreement, dated December 17, 2021, as amended on June 15, 2023 (the “ Trust Agreement ”), by and between the Company and Continental Share Transfer & Trust Company, a New York corporation, as trustee (“ Continental ”), to change the date on which Continental must commence liquidation of the trust account established in connection with the Company’s initial public offering (the “ Trust Account ”) to the earliest of (i) the Company’s completion of an initial business combination and (ii) June 17, 2025 (the “ Extension Date ”).”

CF Acquisition Corp. VII entered into First Amendment to the Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Amendment to investment terms (effective 2024-03-14).

“On March 14, 2024, upon the stockholder approval of the Trust Amendment Proposal (as defined below), the Company entered into the First Amendment (the " Trust Amendment ") to the Investment Management Trust Agreement (the " IMTA ") with Continental Stock Transfer & Trust Company, as trustee (the " Trustee ").”

CF Acquisition Corp. VII entered into Promissory Note with CFAC Holdings VII, LLC valued at up to $1,200,000 (effective 2024-03-14).

“On March 14, 2024, CF Acquisition Corp. VII (the " Company ") issued a promissory note (the " Note ") in the principal amount of up to $1,200,000 to CFAC Holdings VII, LLC (the " Sponsor "), pursuant to which the Sponsor agreed to loan to the Company up to such amount in connection with the extension of the Company’s time to consummate a business combination from March 20, 2024 to March 20, 2025 (or such earlier date as determined by the board of directors of the Company) (the " Extension ").”

AEON Biopharma, Inc. entered into Subscription Agreement with Daewoong Pharmaceutical Co., LTD. valued at $15.0 million (effective 2024-03-19).

“On March 19, 2024, AEON Biopharma, Inc. (“AEON” or the “Company”) and AEON Biopharma Sub, Inc., a subsidiary of the Company (“AEON Sub”), entered into a subscription agreement (the “Subscription Agreement”) with Daewoong Pharmaceutical Co., LTD. (“Daewoong”) relating to the sale and issuance by the Company of senior secured convertible notes (each, a “Convertible Note” and together, the “Convertible Notes”) in the principal amount of up to $15.0 million”

Fusion Pharmaceuticals Inc. entered into Arrangement Agreement with AstraZeneca AB and 15863210 Canada Inc. valued at US$21.00 in cash and one contingent value right representing up to US$3.00 per share (effective 2024-03-18).

“On March 18, 2024, Fusion Pharmaceuticals Inc., a corporation formed under the Canada Business Corporations Act (the “CBCA”) (“Fusion”), AstraZeneca AB, a public company with limited liability (Aktiebolag) incorporated under the laws of Sweden (“Parent”) and 15863210 Canada Inc., a corporation formed under the CBCA (“Purchaser”), entered into a definitive arrangement agreement (the “Arrangement Agreement”), under which Purchaser will acquire all of the issued and outstanding common shares (collectively, the “Shares”) of Fusion on the terms and subject to the conditions set forth therein.”

Assure Holdings Corp. entered into Exchange Agreements with certain holders of convertible notes of Assure valued at $334,342.75 (effective 2024-03-13).

“On March 13, 2024, Assure Holdings Corp., a Nevada corporation (“Assure”) entered into exchange agreements (“Exchange Agreements”) with certain holders (the “Holders”) of convertible notes of Assure (the “Notes”) held by such Holders pursuant to which Assure and the Holders agreed to exchange outstanding principal amounts of Notes for shares of common stock of Assure at a deemed value per share of $0.25.”

Alteryx, Inc. entered into Credit Agreement with SSLP Lending, LLC valued at Initial term loan facility of $550 million; delayed draw term loan facility up to $1,250 million; re (effective 2024-03-19).

“Parent entered into that certain Credit Agreement with Azurite Software Intermediate Holdings, Inc., a Delaware corporation and the sole stockholder of Parent (“ Holdings ”), SSLP Lending, LLC, as administrative agent and collateral agent, and the lenders and letter of credit issuers from time to time party thereto (the “ Credit Agreement ”), which provides for (i) an initial term loan facility in an aggregate principal amount equal to $550 million, (ii) a delayed draw term loan facility in an aggregate principal amount of up to $1,250 million, and (iii) a revolving loan facility in an aggregate principal amount of up to $200 million.”

Enliven Therapeutics, Inc. entered into Purchase Agreement with the purchasers named therein valued at approximately $90 million (effective 2024-03-19).

“On March 19, 2024, Enliven Therapeutics, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of (i) 5,357,144 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at $14.00 per Share, and (ii) pre-funded warrants (the “Pre-Funded Warrants") to purchase 1,071,505 shares of Common Stock”

Sabre Corp entered into New Exchangeable Notes Indenture with U.S. Bank Trust Company, National Association valued at $150.0 million aggregate principal amount (effective 2024-03-19).

“In connection with the previously announced exchange (the “Exchange”) by Sabre GLBL Inc. (“Sabre GLBL”), a wholly-owned subsidiary of Sabre Corporation (“Sabre”), of $150.0 million aggregate principal amount of its outstanding 4.000% Exchangeable Senior Notes due 2025 (the “Existing Exchangeable Notes”) for $150.0 million aggregate principal amount of Sabre GLBL’s newly-issued 7.32% Exchangeable Senior Notes due 2026 (the “New Exchangeable Notes”) and approximately $32.6 million of cash, Sabre GLBL, as issuer, and Sabre and Sabre Holdings Corporation (“Sabre Holdings”), as guarantors, and U.S. Bank Trust Company, National Association, as trustee, entered into an indenture, dated March 19, 2024 (the “New Exchangeable Notes Indenture”), governing the New Exchangeable Notes.”

TON Strategy Co amended Amendment to At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC valued at increase in aggregate offering price from $960,000 to $6,260,000 (effective 2024-03-19).

“On March 19, 2024, the Company entered into the Amendment to At-The-Market Issuance Sales Agreement, dated March 19, 2024 (the “ Amendment ”) to increase the number of shares to be sold in the ATM Offering to $6,260,000”

TON Strategy Co entered into Subscription Agreements with certain institutional investors valued at $5,004,400.08 (effective 2024-03-18).

“On March 18, 2024, Verb Technology Company, Inc, a Nevada corporation (the “Company”), entered into subscription agreements with certain institutional investors (the “Agreements”), pursuant to which the Company agreed to issue and sell to the investors 20,851,667 shares (the “Shares”) of Common Stock, par value $0.0001 per share of the Company at a price of $0.24 per share for gross proceeds to the Company of $5,004,400.08.”

Rithm Capital Corp. entered into Indenture with U.S. Bank Trust Company, National Association valued at $775 million aggregate principal amount of 8.000% senior unsecured notes due 2029 (effective 2024-03-19).

“On March 19, 2024, Rithm Capital Corp. (the “Company”) closed its previously announced private offering of $ 775 million aggregate principal amount of 8.000 % senior unsecured notes due 20 29 (the “Notes”).”

Stimcell Energetics Inc. entered into Private Placement Subscription Agreement with Amir Vahabzadeh valued at 30,000 USD (effective 2024-03-12).

“On March 12, 2024, Amir Vahabzadeh, a director of Cell MedX Corp. (the "Company"), together with his spouse, subscribed for 1,000,000 units (each a "Unit") of the Company at a price of US$0.03 per Unit for total $30,000 in a private placement offering (the "Offering").”

DLT Resolution Inc. entered into Share Purchase Agreement with Global Motor Trade LLC, Global Motor Trade International LLC, SJ Auto Trade LLC, WEC International LLC valued at combined annual gross revenue of USD $50,858,000 (effective 2024-03-11).

“On March 11, 2024, DLT Resolution Inc. (the “ Company ” or “ we ”) entered into and closed the transactions contemplated by the definitive share purchase agreement (share for share exchange) (the “ Share Purchase Agreement ”) by and among the Companies,Global Motor Trade LLC, Global Motor Trade International LLC, SJ Auto Trade LLC, WEC International LLC.”

GTJ REIT, INC. entered into Loan Agreement with American General Life Insurance Company valued at $125 million (effective 2024-03-15).

“On March 15, 2024 (the “Closing Date”), certain indirect subsidiaries (collectively, the “Borrowers”) of GTJ REIT, Inc., a Maryland corporation (the “Company”), refinanced the current outstanding debt on certain properties (the “Refinancing”) by entering into a new loan agreement (the “Loan Agreement”) with American General Life Insurance Company as lender (the “Lender”). The Loan Agreement provides for a secured loan in the aggregate principal amount of $125 million (the “Loan Facility”).”

CAMBER ENERGY, INC. terminated MIPA with RESC Renewables Holdings, LLC (effective 2024-03-13).

“On March 13, 2024, the Company and the Seller agreed by mutual consent and pursuant to the terms of a termination agreement (the “ Termination Agreement ”) to terminate the MIPA effective March 13, 2024”

LIQUIDMETAL TECHNOLOGIES INC amended First Amendment to License Agreement with Amorphology Inc. (effective 2024-03-15).

“On March 15, 2024, Liquidmetal Technologies, Inc. (the “Company”) entered into a First Amendment to License Agreement (the “First Amendment”) with Amorphology Inc. (“Amorphology”), which amended a License Agreement, dated November 22, 2019, previously entered into by the Company and Amorphology (the “Original License Agreement,” and together with the First Amendment, the “Amended License Agreement”).”

SWK Holdings Corp entered into Exclusive Option and Asset Purchase Agreement with AptarGroup, Inc. valued at low-single digit million dollar option fee (effective 2024-03-13).

“On March 13, 2024, Enteris Biopharma, Inc. (“Enteris”), a wholly owned subsidiary of SWK Holdings Corporation (“SWK”), and SWK entered into an exclusive option and asset purchase agreement (the “Exclusive Option and Asset Purchase Agreement”) with AptarGroup, Inc. (“Aptar”), pursuant to which Enteris granted to Aptar an exclusive option (the “Option”) to acquire certain of Enteris’s assets related to its business of providing good manufacturing practice (GMP) manufacturing and clinical supply services through Phase 1 and 2 to third parties (collectively, the “Assets”), subject to certain exclusions.”

XCel Brands, Inc. entered into Underwriting Agreement with Craig-Hallum Capital Group LLC, as representative of the underwriters valued at approximately $1,750,000 (effective 2024-03-15).

“On March 15, 2024, Xcel Brands, Inc. (the “Registrant”) entered into an underwriting agreement (the “Underwriting Agreement”) with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters named therein (the “Underwriters”), relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,421 shares (the “Shares”) of the Registrant’s common stock, par value $0.001 per share (“Common Stock”) at a price to the public of $0.65 per Share.”

INTELLINETICS, INC. amended Amendment to all of its 12% Subordinated Promissory Notes with certain accredited investors (effective 2024-03-13).

“On March 13, 2024, Intellinetics, Inc. (the “Company”) entered into an Amendment to all of its 12% Subordinated Promissory Notes, dated April 1, 2022 (the “Notes”) with certain accredited investors.”

Strategy Inc entered into Convertible Note Offering with Citigroup Global Markets Inc. valued at $603.75 million aggregate principal amount of 0.875% convertible senior notes due 2031 (effective 2024-03-18).

“On March 18, 2024, MicroStrategy Incorporated (the “Company”) completed its previously announced private offering of 0.875% convertible senior notes due 2031 (the “notes”).”

SONIC AUTOMOTIVE INC amended Sixth Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent, and the lenders listed therein valued at decrease the aggregate commitments under the Floor Plan Facilities by $550.00 million, from $2.95 bi (effective 2024-03-13).

“On March 13, 2024 (the “Effective Date”), Sonic Automotive, Inc. (the “Company”) and certain of its subsidiaries entered into the Sixth Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, revolving swing line lender, new vehicle swing line lender, used vehicle swing line lender, letter of credit issuer and a lender, BMW Financial Services NA, LLC, JPMorgan Chase Bank, N.A., Mercedes-Benz Financial Services USA LLC, Toyota Motor Credit Corporation, PNC Bank, National Association, VW Credit, Inc., American Honda Finance Corporation, U.S. Bank National Association, Wells Fargo Bank, National Association, MassMutual Asset Finance LLC, TD Bank, N.A., World Omni Financial Corp., and First National Bank of Pennsylvania as lenders.”

COLUMBUS MCKINNON CORP amended Fourth Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and the other agents parties thereto valued at reduces the interest rate margin applicable to the term loan B outstanding under the Credit Agreemen (effective 2024-03-18).

“On March 18, 2024, Columbus McKinnon Corporation (the “Company”) entered into a Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, dated as of May 14, 2021, by and among the Company, Columbus McKinnon EMEA GmbH, the lenders from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents parties thereto, as amended (the “Credit Agreement”).”

TRINITY INDUSTRIES INC entered into Loan Agreement with Atlas Securitized Products Administration, L.P., as agent, U.S. Bank Trust Company, National Association, as collateral agent and depositary, and the banks and other lending institutions from time to time party thereto valued at approximately $660,000,000 (effective 2024-03-15).

“On March 15, 2024, Trinity Industries Leasing Company, a Delaware corporation (“TILC”) and wholly-owned subsidiary of Trinity Industries, Inc. (the “Company”), and Trinity Rail Leasing Warehouse Trust, a Delaware statutory trust (“TRLWT”) in which TILC is the sole beneficiary, entered into a Warehouse Loan Agreement dated as of March 15, 2024 (the “Loan Agreement”) among the banks and other lending institutions from time to time party thereto, Atlas Securitized Products Administration, L.P., as agent (the “Agent”), and U.S. Bank Trust Company, National Association, not in its individual capacity, but solely in its capacity as collateral agent and depositary.”

BEAZER HOMES USA INC amended Amendment to Credit Agreement with JPMorgan Chase Bank, N.A., as an issuing lender and administrative agent (effective 2024-03-15).

“On March 15, 2024, the Company executed an amendment (the “Amendment”) to the Credit Agreement, dated as of October 13, 2022, among the Company, the several lenders from time to time parties thereto and JPMorgan Chase Bank, N.A., as an issuing lender and administrative agent (as amended on and prior to March 15, 2024, the “Credit Agreement”).”

BEAZER HOMES USA INC entered into Indenture with Regions Bank, as trustee, and the Guarantors valued at $250 million (effective 2024-03-15).

“On March 15, 2024, Beazer Homes USA, Inc. (the “Company”) issued and sold $250 million aggregate principal amount of its 7.500% Senior Notes due 2031 (the “Notes”) through a private placement”

UFP TECHNOLOGIES INC amended Amendment with Intuitive Surgical SARL valued at approximately $500 million (effective 2024-03-18).

“On March 18, 2024, through a wholly-owned subsidiary, UFP Technologies, Inc. (“UFP” or the “Company”) and Intuitive Surgical SARL, one of the Company’s strategic medical customers (the “Customer”), entered into that certain amendment (the “Amendment”) to the manufacturing supply agreement dated April 25, 2014 as amended”

QUICKLOGIC Corp entered into Common Stock Purchase Agreements with certain institutional investors and their affiliated entities valued at gross proceeds of approximately $3.56 million (effective 2024-03-13).

“On March 13, 2024, QuickLogic Corporation (the “Company”) entered into Common Stock Purchase Agreements with certain institutional investors and their affiliated entities for the sale of an aggregate of 222,500 shares of common stock, par value $0.001 (the “Common Stock”), in a registered direct offering.”

CLEVELAND-CLIFFS INC. entered into Indenture with U.S. Bank Trust Company, National Association valued at $825,000,000 aggregate principal amount of 7.000% senior unsecured guaranteed notes due 2032 (effective 2024-03-18).

“On March 18, 2024, Cleveland-Cliffs Inc. (the “Company”) issued $825,000,000 aggregate principal amount of 7.000% senior unsecured guaranteed notes due 2032 (the “Notes”) in a private transaction exempt from the registration requirements of the Securities Act of 1933 (the “Securities Act”).”

INTRUSION INC entered into Exchange Agreement with Streeterville Capital, LLC (effective 2024-03-15).

“On March 15, 2024, Intrusion Inc. (the “Company”), entered into and closed an Exchange Agreement with Streeterville Capital, LLC (“Streeterville”).”

IPALCO ENTERPRISES, INC. entered into Seventy-Second Supplemental Indenture dated March 1, 2024 with The Bank of New York Mellon Trust Company, N.A. valued at $650 million aggregate principal amount of 5.700% First Mortgage Bonds due 2054 (effective 2024-03-18).

“IPALCO has entered into a Pledge Agreement Supplement with The Bank of New York Mellon Trust Company, N.A., as successor collateral agent (the “Collateral Agent”), dated March 14, 2024 (the “Pledge Agreement Supplement”), to the Pledge Agreement between IPALCO and The Bank of New York Mellon Trust Company, N.A., as successor to Bank One, National Association, dated November 14, 2001, as supplemented by a Pledge Agreement Supplement dated June 25, 2015, a Pledge Agreement Supplement dated August 22, 2017, a Pledge Agreement Supplement dated October 31, 2018, and a Pledge Agreement Supplement dated April 14, 2020, each by IPALCO in favor of the Collateral Agent.”

IPALCO ENTERPRISES, INC. entered into Registration Rights Agreement dated March 14, 2024 with J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc. valued at Registration rights agreement for exchange offer of the Notes (effective 2024-03-14).

“IPALCO has also agreed to file a registration statement with respect to a registered offer to exchange the Notes for new exchange notes, which will have terms substantially identical in all material respects to the Notes (except that the new exchange notes will not contain terms with respect to transfer restrictions and additional interest) under the Securities Act, with the Securities and Exchange Commission pursuant to a Registration Rights Agreement, dated as of March 14, 2024 (the “Registration Rights Agreement”), among IPALCO and J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc., as representatives of the initial purchasers of the Notes.”